Cargando…

Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration

Dementia is a chronic, irreversible condition marked by memory loss, cognitive decline, and mental instability. It is clinically related to various progressive neurological diseases, including Parkinson’s disease, Alzheimer’s disease, and Huntington’s. The primary cause of neurological disorders is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehan, Sidharth, Bhalla, Sonalika, Siddiqui, Ehraz Mehmood, Sharma, Nidhi, Shandilya, Ambika, Khan, Andleeb
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921673/ https://www.ncbi.nlm.nih.gov/pubmed/35300067 http://dx.doi.org/10.2147/DNND.S247153

Ejemplares similares

Potential role of IGF-1/GLP-1 signaling activation in intracerebral hemorrhage
por: Siddiqui, Ehraz Mehmood, et al.
Publicado: (2022)

Neuroprotective efficacy of 4-Hydroxyisoleucine in experimentally induced intracerebral hemorrhage
por: Mehmood Siddiqui, Ehraz, et al.
Publicado: (2021)

Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats
por: Rajdev, Kajal, et al.
Publicado: (2020)

Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope
por: Nabi, Showkat Ul, et al.
Publicado: (2022)

Involvement of Phytochemical-Encapsulated Nanoparticles’ Interaction with Cellular Signalling in the Amelioration of Benign and Malignant Brain Tumours
por: Mehan, Sidharth, et al.
Publicado: (2022)

Understanding Acquired Brain Injury: A Review
por: Goldman, Liam, et al.
Publicado: (2022)

Glucagon-like peptide-1 analogues: An overview
por: Gupta, Vishal
Publicado: (2013)

Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism
por: Khera, Rishabh, et al.
Publicado: (2022)

Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity
por: Shandilya, Ambika, et al.
Publicado: (2022)

New concept of the glucagon‐like peptide‐1 signaling pathway on pancreatic insulin secretion
por: Kaku, Kohei
Publicado: (2019)

Insulin Reciprocally Regulates Glucagon Secretion in Humans
por: Cooperberg, Benjamin A., et al.
Publicado: (2010)

Glucagon-like Peptide-1 Receptor Analogues for the Treatment of Obesity
por: Williams, David M, et al.
Publicado: (2022)

Postprandial Insulin Secretion After Gastric Bypass Surgery: The Role of Glucagon-Like Peptide 1
por: Holst, Jens Juul
Publicado: (2011)

Osteocalcin Induces Release of Glucagon-Like Peptide-1 and Thereby Stimulates Insulin Secretion in Mice
por: Mizokami, Akiko, et al.
Publicado: (2013)

Glucagon Secreting Cells Responds to Insulin Secretion In vitro Using Immunocytochemistry
por: Aswar, MK, et al.
Publicado: (2010)

Effects of Glucagon-Like-Peptide-1 Analogue Treatment in Genetic Obesity
por: Welling, Mila Sofie, et al.
Publicado: (2021)

Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis
por: Tiano, Joseph P., et al.
Publicado: (2015)

Protective potential of glucagon like peptide 2 (GLP-2) against the neurodegeneration
por: Amato, Antonella, et al.
Publicado: (2019)

Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases
por: Lee, Young-Sun, et al.
Publicado: (2018)

Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
por: Kimura, Tomohiko, et al.
Publicado: (2022)

Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans
por: Salehi, Marzieh, et al.
Publicado: (2011)

Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings
por: Duggal, Pallavi, et al.
Publicado: (2019)

Glucagon-like peptide-1 analogues - an efficient therapeutic option for the severe insulin resistance of lipodystrophic syndromes: two case reports
por: Oliveira, Joana, et al.
Publicado: (2017)

Investigating the Glucagon Receptor and Glucagon-Like Peptide 1 Receptor Activity of Oxyntomodulin-Like Analogues in Male Wistar Rats
por: Price, Samantha L., et al.
Publicado: (2015)

Influence of Insulin in the Ventromedial Hypothalamus on Pancreatic Glucagon Secretion In Vivo
por: Paranjape, Sachin A., et al.
Publicado: (2010)

Glucagon‐like peptide‐1 and glucose‐dependent insulinotropic peptide: effects alone and in combination on insulin secretion and glucose disappearance in mice
por: Pacini, Giovanni, et al.
Publicado: (2017)

Nutrient consumption-dependent association of a glucagon-like peptide-1 receptor gene polymorphism with insulin secretion
por: Nishiya, Yuki, et al.
Publicado: (2020)

Multiple Factors Related to the Secretion of Glucagon-Like Peptide-1
por: Wang, XingChun, et al.
Publicado: (2015)

Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid
por: Fernandes, Maria F., et al.
Publicado: (2022)

APP‐derived peptides reflect neurodegeneration in frontotemporal dementia
por: Illán‐Gala, Ignacio, et al.
Publicado: (2019)

Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study
por: Kuwata, Hitoshi, et al.
Publicado: (2021)

Subthreshold α (2)-Adrenergic Activation Counteracts Glucagon-Like Peptide-1 Potentiation of Glucose-Stimulated Insulin Secretion
por: Pan, Minglin, et al.
Publicado: (2011)

Chicken Intestinal L Cells and Glucagon-like Peptide-1 Secretion
por: Hiramatsu, Kohzy
Publicado: (2020)

Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis
por: Shyangdan, Deepson S, et al.
Publicado: (2010)

Glucagon-Like Peptide-2 Analogue ZP1849 Augments Colonic Anastomotic Wound Healing
por: Kjaer, Marie, et al.
Publicado: (2020)

Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?
por: Basalay, Maryna V., et al.
Publicado: (2020)

Effects of glucagon‐like peptide‐1 analogue treatment in genetic obesity: A case series
por: Welling, Mila S., et al.
Publicado: (2021)

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
por: Vergari, Elisa, et al.
Publicado: (2019)

Glucose, adrenaline and palmitate antagonistically regulate insulin and glucagon secretion in human pseudoislets
por: Lorza-Gil, Estela, et al.
Publicado: (2019)

Insulin-like growth factor-1 is a negative modulator of glucagon secretion
por: Mancuso, Elettra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_10414qr6uiu6icetsvf1gdin3m